These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 357024)
21. [Neurotransmitters and epilepsy. The antiepileptic effect of biogenic amines gamma-aminobutyric-acid and taurine in patients with epilepsy (author's transl)]. Schmidt D Nervenarzt; 1980 Oct; 51(10):582-90. PubMed ID: 6109260 [No Abstract] [Full Text] [Related]
22. Opiates, opioid peptides and psychiatry. Davis GC; Buchsbaum MS; Bunney WE Ann N Y Acad Sci; 1981; 362():67-75. PubMed ID: 7020533 [No Abstract] [Full Text] [Related]
24. [Endorphins. Physiological and pharmacological aspects, and research in psychiatry]. Leboyer M Encephale; 1986; 12(2):45-62. PubMed ID: 3527685 [TBL] [Abstract][Full Text] [Related]
25. Psychological measurements in Psychopharmacology. Introduction. Pichot P Mod Probl Pharmacopsychiatry; 1974; 7(0):1-7. PubMed ID: 4153453 [No Abstract] [Full Text] [Related]
26. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. Chang L; Cloak CC; Ernst T J Clin Psychiatry; 2003; 64 Suppl 3():7-14. PubMed ID: 12662128 [TBL] [Abstract][Full Text] [Related]
27. Dendritic spine hypoplasticity and downregulation of reelin and GABAergic tone in schizophrenia vulnerability. Costa E; Davis J; Grayson DR; Guidotti A; Pappas GD; Pesold C Neurobiol Dis; 2001 Oct; 8(5):723-42. PubMed ID: 11592844 [TBL] [Abstract][Full Text] [Related]
28. Brain amines and peptides--their relevance to psychiatry. Smith GC; Copolov D Aust N Z J Psychiatry; 1979 Dec; 13(4):283-91. PubMed ID: 44187 [TBL] [Abstract][Full Text] [Related]
29. [Neuropeptide role in the etiology, pathogenesis and clinical aspects of mental diseases]. Bakharev VD; Tikhomirov SM Sov Med; 1984; (6):50-3. PubMed ID: 6147020 [No Abstract] [Full Text] [Related]
30. Effects of chlormezanone on anxiety and tension: a double blind study. Friedman D; Moskowitz MD; Rosen M; Rossman M; Sheppard C; Merlis S Curr Ther Res Clin Exp; 1966 Jan; 8(1):7-11. PubMed ID: 4955147 [No Abstract] [Full Text] [Related]
31. [Anti-anxiety drug therapy of bipolar disorders--clinical and basic study]. Motohashi N Seishin Shinkeigaku Zasshi; 1993; 95(10):787-92. PubMed ID: 7905648 [No Abstract] [Full Text] [Related]
33. Glial fibrillary acidic protein mRNA levels in the cingulate cortex of individuals with depression, bipolar disorder and schizophrenia. Webster MJ; O'Grady J; Kleinman JE; Weickert CS Neuroscience; 2005; 133(2):453-61. PubMed ID: 15885920 [TBL] [Abstract][Full Text] [Related]
34. Oxidative stress as an etiological factor and a potential treatment target of psychiatric disorders. Part 2. Depression, anxiety, schizophrenia and autism. Smaga I; Niedzielska E; Gawlik M; Moniczewski A; Krzek J; Przegaliński E; Pera J; Filip M Pharmacol Rep; 2015 Jun; 67(3):569-80. PubMed ID: 25933971 [TBL] [Abstract][Full Text] [Related]
35. [Affective psychoses and their biochemical correlates (author's transl)]. Opavský J Cas Lek Cesk; 1979; 118(39):1200-4. PubMed ID: 230902 [No Abstract] [Full Text] [Related]
36. [The clinical significance of neuropeptides]. van Praag HM Ned Tijdschr Geneeskd; 1979 Sep; 123(37):1597-9. PubMed ID: 481631 [No Abstract] [Full Text] [Related]
37. Biochemistry of mental disorders. Report of a WHO Scientific Group. World Health Organ Tech Rep Ser; 1969; 427():1-40. PubMed ID: 4980629 [No Abstract] [Full Text] [Related]